Recent News

• 04.24.2025 - Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time
• 04.22.2025 - Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor
• 04.14.2025 - Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario
• 04.10.2025 - Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™
• 04.03.2025 - Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico
• 04.01.2025 - Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

Recent Filings

• 04.24.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.24.2025 - EX-99.1 EX-99.1
• 04.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.22.2025 - EX-99.1 EX-99.1
• 04.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.21.2025 - EX-99.1 EX-99.1
• 04.14.2025 - EX-99.1 EX-99.1
• 04.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - EX-99.1 EX-99.1
• 04.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]